Literature DB >> 15128046

Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants.

David R Nelson1, Darryl C Zeldin, Susan M G Hoffman, Lois J Maltais, Hester M Wain, Daniel W Nebert.   

Abstract

OBJECTIVES: Completion of both the mouse and human genome sequences in the private and public sectors has prompted comparison between the two species at multiple levels. This review summarizes the cytochrome P450 (CYP) gene superfamily. For the first time, we have the ability to compare complete sets of CYP genes from two mammals. Use of the mouse as a model mammal, and as a surrogate for human biology, assumes reasonable similarity between the two. It is therefore of interest to catalog the genetic similarities and differences, and to clarify the limits of extrapolation from mouse to human.
METHODS: Data-mining methods have been used to find all the mouse and human CYP sequences; this includes 102 putatively functional genes and 88 pseudogenes in the mouse, and 57 putatively functional genes and 58 pseudogenes in the human. Comparison is made between all these genes, especially the seven main CYP gene clusters. RESULTS AND
CONCLUSIONS: The seven CYP clusters are greatly expanded in the mouse with 72 functional genes versus only 27 in the human, while many pseudogenes are present; presumably this phenomenon will be seen in many other gene superfamily clusters. Complete identification of all pseudogene sequences is likely to be clinically important, because some of these highly similar exons can interfere with PCR-based genotyping assays. A naming procedure for each of four categories of CYP pseudogenes is proposed, and we encourage various gene nomenclature committees to consider seriously the adoption and application of this pseudogene nomenclature system.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15128046     DOI: 10.1097/00008571-200401000-00001

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  271 in total

1.  Methodological approaches to cytochrome P450 profiling in embryos.

Authors:  Jared V Goldstone; John J Stegeman
Journal:  Methods Mol Biol       Date:  2012

2.  Molecular characterization of the Camelus dromedarius putative cytochrome P450s genes.

Authors:  Mohammad Saud Alanazi; Hesham Mahmoud Saeed; Farid Shokry Ataya; Mohammad Dawoud Bazzi
Journal:  Protein J       Date:  2010-07       Impact factor: 2.371

3.  Altered cytochrome P450 expression in mice during pregnancy.

Authors:  Kwi Hye Koh; Hui Xie; Ai-Ming Yu; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2010-10-22       Impact factor: 3.922

4.  Systematic genetic and genomic analysis of cytochrome P450 enzyme activities in human liver.

Authors:  Xia Yang; Bin Zhang; Cliona Molony; Eugene Chudin; Ke Hao; Jun Zhu; Andrea Gaedigk; Christine Suver; Hua Zhong; J Steven Leeder; F Peter Guengerich; Stephen C Strom; Erin Schuetz; Thomas H Rushmore; Roger G Ulrich; J Greg Slatter; Eric E Schadt; Andrew Kasarskis; Pek Yee Lum
Journal:  Genome Res       Date:  2010-06-10       Impact factor: 9.043

Review 5.  A brief overview of mouse models of pulmonary arterial hypertension: problems and prospects.

Authors:  Jose Gomez-Arroyo; Sheinei J Saleem; Shiro Mizuno; Aamer A Syed; Harm J Bogaard; Antonio Abbate; Laimute Taraseviciene-Stewart; Yon Sung; Donatas Kraskauskas; Daniela Farkas; Daniel H Conrad; Mark R Nicolls; Norbert F Voelkel
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-02-03       Impact factor: 5.464

6.  Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset.

Authors:  Adam S Gordon; Holly K Tabor; Andrew D Johnson; Beverly M Snively; Themistocles L Assimes; Paul L Auer; John P A Ioannidis; Ulrike Peters; Jennifer G Robinson; Lara E Sucheston; Danxin Wang; Nona Sotoodehnia; Jerome I Rotter; Bruce M Psaty; Rebecca D Jackson; David M Herrington; Christopher J O'Donnell; Alexander P Reiner; Stephen S Rich; Mark J Rieder; Michael J Bamshad; Deborah A Nickerson
Journal:  Hum Mol Genet       Date:  2013-11-26       Impact factor: 6.150

7.  Basal and inducible CYP1 mRNA quantitation and protein localization throughout the mouse gastrointestinal tract.

Authors:  Shigeyuki Uno; Nadine Dragin; Marian L Miller; Timothy P Dalton; Frank J Gonzalez; Daniel W Nebert
Journal:  Free Radic Biol Med       Date:  2007-11-12       Impact factor: 7.376

8.  Effect of the active ingredient of Kaempferia parviflora, 5,7-dimethoxyflavone, on the pharmacokinetics of midazolam.

Authors:  Wataru Ochiai; Hiroko Kobayashi; Satoshi Kitaoka; Mayumi Kashiwada; Yuya Koyama; Saho Nakaishi; Tomomi Nagai; Masaki Aburada; Kiyoshi Sugiyama
Journal:  J Nat Med       Date:  2018-03-17       Impact factor: 2.343

9.  Evolution of the CYP2ABFGST gene cluster in rat, and a fine-scale comparison among rodent and primate species.

Authors:  Shengyong Hu; Haoyi Wang; Alyssa A Knisely; Shanti Reddy; David Kovacevic; Zhi Liu; Susan M G Hoffman
Journal:  Genetica       Date:  2007-09-18       Impact factor: 1.082

Review 10.  Trichloroethylene biotransformation and its role in mutagenicity, carcinogenicity and target organ toxicity.

Authors:  Lawrence H Lash; Weihsueh A Chiu; Kathryn Z Guyton; Ivan Rusyn
Journal:  Mutat Res Rev Mutat Res       Date:  2014 Oct-Dec       Impact factor: 5.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.